Related references
Note: Only part of the references are listed.Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof-of-concept study
Maxime Meloche et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration
Lisa K. Stamp et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
Kazi Mirajul Hoque et al.
NATURE COMMUNICATIONS (2020)
Sex Differences in Urate Handling
Victoria L. Halperin Kuhns et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcome
Janet K. Coller et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Pharmacogenetics of statins treatment: Efficacy and safety
Zi-Wan Guan et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank
Ravi K. Narang et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2
Makiko Nakamura et al.
DRUG METABOLISM AND PHARMACOKINETICS (2018)
Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis
Mary C. Wallace et al.
RHEUMATOLOGY (2018)
ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol
Lisa K. Stamp et al.
DRUG METABOLISM AND PHARMACOKINETICS (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
R. L. Roberts et al.
PHARMACOGENOMICS JOURNAL (2017)
Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits
Nathalie Chami et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals
John D. Eicher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Michael M. Givertz et al.
CIRCULATION (2015)
Genome-Wide Association Study Identifies ABCG2 (BCRP) as an Allopurinol Transporter and a Determinant of Drug Response
C. C. Wen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Genetic markers associated with cutaneous adverse drug reactions to allopurinol: aysystematic review
Samantha Jarjour et al.
PHARMACOGENOMICS (2015)
Validation of fatty acid intakes estimated by a food frequency questionnaire using erythrocyte fatty acid profiling in the Montreal Heart Institute Biobank
V. Turcot et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2015)
Association of Functional Polymorphism rs2231142 ( Q141K) in the ABCG2 Gene With Serum Uric Acid and Gout in 4 US Populations The PAGE Study
Lili Zhang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care
Marianne K. DeGorter et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Anna Koettgen et al.
NATURE GENETICS (2013)
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
Joerg Koenig et al.
PHARMACOLOGICAL REVIEWS (2013)
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
Takeo Nakanishi et al.
CHINESE JOURNAL OF CANCER (2012)
Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction The GEOSTAT-1 Study
Kristian M. Bailey et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia
Naoto Takahashi et al.
JOURNAL OF HUMAN GENETICS (2010)
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
J. E. Keskitalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations
Melanie Kolz et al.
PLOS GENETICS (2009)
Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2)
Ulrike Gradhand et al.
DRUG METABOLISM REVIEWS (2008)
Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract
H Gutmann et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Share Paper
